FDA Extends PDUFA Date for Priority Review of NDA for Salix Pharma's (SLXP) Crofelemer Tablets
Go back to FDA Extends PDUFA Date for Priority Review of NDA for Salix Pharma's (SLXP) Crofelemer Tablets| Salix Pharmaceuticals Ltd (NASDAQ: SLXP) | Delayed: 172.81 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $172.81 | 52 Week High | $172.98 | |||
| Open | $0.00 | 52 Week Low | $86.00 | |||
| Day High | $172.81 | P/E | 104.10 | |||
| Day Low | $172.81 | EPS | $1.66 | |||
| Volume | 28,701 | |||||
